Articles

New government estimates show that nearly 24 million people, 8% of the population in the United States have diabetes, an increase of more than 3 million in two years.

The study compares the risk of incident diabetes associated with fasting plasma glucose levels in the normal range below 100mg/dL, controlling for other risk factors. Subjects with glucose levels of 95 to 99 mg/dL were 2.33 times more likely to develop diabetes.

Older adults with poorly controlled diabetes may have three times the risk of developing tuberculosis than those who achieve better diabetes control, study findings suggest.

In a small study of overweight and obese adults, 3 months of aerobic exercise, with no change in diet, led to a significant decrease in body fat and a spontaneous decrease in caloric intake. The percentage of weight loss and the reduction in caloric intake correlated positively and significantly with …

A novel microsphere-based vaccine targeting dendritic cells prevents and reverses new-onset autoimmune diabetes in a mouse model, according to a report in the June issue of Diabetes.

Microsoft Corp., Google Inc., and dozens of organizations promoting consumer adoption of electronic personal health records agreed for the first time on a comprehensive set of privacy protections.

Factors associated with weight regain after substantial weight loss are identified in a study in which data from the 1999 – 2002 National Health and Nutrition Examination Survey (NHANES) were analyzed.

Dietary patterns affect the risk for type 2 diabetes to a greater extent vs intake of specific food groups, according to findings from the Multi-Ethnic Study of Atherosclerosis (MESA), reported in the June 10 Online First issue of Diabetes Care.

Physical activity may help counter the adverse effect diabetes seems to have on breast cancer risk in Hispanic women’

People with diabetes, and physicians treating them, have become excited in recent years by insulin analogs due to their rapid window of action but recent research from Generex Biotechnology shows that the advantages of insulin analogs may be illusory.